Search

everythinglearnresearchcommunity

for

Search:↓

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Astressin-B can reverse and prevent hair loss in stressed mice.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Baricitinib is effective for severe alopecia areata but has some side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

AH-001 could be a safer and more effective treatment for hair loss.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.